New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
AN2 Therapeutics, Inc.
ANTX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

31M

Biotechnology

Next Earning date - 14 Nov 2024

31M

Biotechnology

Next Earning date - 14 Nov 2024

1.05USD
Shape0.02 ( 1.94%)
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

-68%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

95%

Quote Panel

Shape
Updated October 19, 2024
1W 1.94 % 1M 0.00 % 3M -63.92 % 1Y -93.00 %

Key Metrics

Shape
  • Market Cap

    31.33M


  • Shares Outstanding

    29.84M


  • Share in Float

    19.39M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    1.05


  • Average Volume

    601357


  • Beta

    -0.221


  • Range

    0.87-22.22


  • Industry

    Biotechnology


  • Website

    https://www.an2therapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

391.68x

P/S Ratio

0.32x

P/B Ratio

0.0

Debt/Equity

-80821.3%

Net Margin

$-2.2

EPS

How ANTX compares to sector?

P/E Ratio

Relative Strength

Shape

ANTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$33M

ShapeNaN%

2025-Revenue

$1.54

Shape-221%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Evercore ISI

downgrade

Previous: Not converted

2024-08-09

Now: Underperform

Leerink Partners

upgrade

Previous: Market Perform

2024-07-03

Now: Outperform

JMP Securities

upgrade

Previous: Not converted

2024-04-02

Now: Outperform

Leerink Partners

downgrade

Previous: Not converted

2024-02-13

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.59
vs -0.49

Q4.22

arrow
arrow

N/A

-0.61
vs -0.42

Q1.23

arrow
arrow

N/A

-0.79
vs -2.98

Q2.23

arrow
arrow

N/A

-0.81
vs -0.53

Q3.23

arrow
arrow

N/A

-0.65
vs -0.59

Q4.23

arrow
arrow

N/A

-0.57
vs -0.61

Q1.24

arrow
arrow

N/A

-0.56
vs -0.79

Q2.24

arrow
arrow

N/A

-0.48
vs -0.81

Q3.24

arrow
arrow

N/A

-0.45
vs -0.65

Q4.24

arrow
arrow

N/A

-0.36
vs -0.57

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

80K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-10%

-0.10
vs -0.08

Q4.22

arrow
arrow

-13%

-0.13
vs -0.10

Q1.23

arrow
arrow

-18%

-0.18
vs -0.13

Q2.23

arrow
arrow

-18%

-0.18
vs -0.18

Q3.23

arrow
arrow

-12%

-0.12
vs -0.18

Q4.23

arrow
arrow

-14%

-0.14
vs -0.12

Q1.24

arrow
arrow

-15%

-0.15
vs -0.14

Q2.24

arrow
arrow

-15%

-0.15
vs -0.15

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

35

35
vs 34

3%

Q4.22

arrow
arrow

35

35
vs 35

NA

Q1.23

arrow
arrow

37

37
vs 35

6%

Q2.23

arrow
arrow

31

31
vs 37

-16%

Q3.23

arrow
arrow

37

37
vs 31

19%

Q4.23

arrow
arrow

51

51
vs 37

38%

Q1.24

arrow
arrow

54

54
vs 51

6%

Q2.24

arrow
arrow

45

45
vs 54

-17%

Earnings Growth

Latest News

ANTX

247wallst.com

10 hours ago